139 related articles for article (PubMed ID: 23396293)
1. OC125, M11 and OV197 epitopes are not uniformly distributed in the tandem-repeat region of CA125 and require the entire SEA domain.
Bressan A; Bozzo F; Maggi CA; Binaschi M
Dis Markers; 2013; 34(4):257-67. PubMed ID: 23396293
[TBL] [Abstract][Full Text] [Related]
2. Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies.
Wang CW; Hanson EK; Minkoff L; Whelan RJ
Cancer Biomark; 2023; 37(2):85-94. PubMed ID: 37248884
[TBL] [Abstract][Full Text] [Related]
3. Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies.
Wang CW; Hanson EK; Minkoff L; Whelan RJ
bioRxiv; 2023 Feb; ():. PubMed ID: 36798296
[TBL] [Abstract][Full Text] [Related]
4. Characterization of binding epitopes of CA125 monoclonal antibodies.
Marcos-Silva L; Narimatsu Y; Halim A; Campos D; Yang Z; Tarp MA; Pereira PJ; Mandel U; Bennett EP; Vakhrushev SY; Levery SB; David L; Clausen H
J Proteome Res; 2014 Jul; 13(7):3349-59. PubMed ID: 24850311
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16.
Yin BW; Lloyd KO
J Biol Chem; 2001 Jul; 276(29):27371-5. PubMed ID: 11369781
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.
Yin BW; Dnistrian A; Lloyd KO
Int J Cancer; 2002 Apr; 98(5):737-40. PubMed ID: 11920644
[TBL] [Abstract][Full Text] [Related]
7. A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.
Wang CW; Weaver SD; Boonpattrawong N; Schuster-Little N; Patankar M; Whelan RJ
Cancer Res Commun; 2024 Jan; 4(1):253-263. PubMed ID: 38197671
[TBL] [Abstract][Full Text] [Related]
8. Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer.
Sharma SK; Suresh MR; Wuest FR
Protein Expr Purif; 2014 Oct; 102():27-37. PubMed ID: 25079010
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker.
White B; Patterson M; Karnwal S; Brooks CL
Proteins; 2022 May; 90(5):1210-1218. PubMed ID: 35037700
[TBL] [Abstract][Full Text] [Related]
10. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine.
Nustad K; Bast RC; Brien TJ; Nilsson O; Seguin P; Suresh MR; Saga T; Nozawa S; Børmer OP; de Bruijn HW; Nap M; Vitali A; Gadnell M; Clark J; Shigemasa K; Karlsson B; Kreutz FT; Jette D; Sakahara H; Endo K; Paus E; Warren D; Hammarström S; Kenemans P; Hilgers J
Tumour Biol; 1996; 17(4):196-219. PubMed ID: 8685601
[TBL] [Abstract][Full Text] [Related]
11. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique.
Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U
Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128
[TBL] [Abstract][Full Text] [Related]
12. Expression and epitope characterization of a recombinant CA 125 repeat: fourth report from the ISOBM TD-1 workshop.
Warren DJ; Nustad K; Beard JB; O'Brien TJ
Tumour Biol; 2009; 30(2):51-60. PubMed ID: 19321947
[TBL] [Abstract][Full Text] [Related]
13. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?
Reinsberg J; Krebs D
Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.
Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF
Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426
[TBL] [Abstract][Full Text] [Related]
16. [Heterogeneity of the CA125 antigen that coexpresses sialyl Tn and CA19-9 antigens].
Kobayashi H; Ohi H; Shinohara H; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):980-6. PubMed ID: 8371024
[TBL] [Abstract][Full Text] [Related]
17. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
18. Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.
Uttenreuther-Fischer MM; Feistel H; Wolf F; Jäger W
J Clin Lab Anal; 1997; 11(2):94-103. PubMed ID: 9058243
[TBL] [Abstract][Full Text] [Related]
19. Methods for identification of CA125 from ovarian cancer ascites by high resolution mass spectrometry.
Weiland F; Fritz K; Oehler MK; Hoffmann P
Int J Mol Sci; 2012; 13(8):9942-9958. PubMed ID: 22949840
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop.
Nap M; Vitali A; Nustad K; Bast RC; O'Brien TJ; Nilsson O; Seguin P; Suresh MR; Børmer OP; Saga T; de Bruijn HW; Nozawa S; Kreutz FT; Jette D; Sakahara H; Gadnell M; Endo K; Barlow EH; Warren D; Paus E; Hammarström S; Kenemans P; Hilgers J
Tumour Biol; 1996; 17(6):325-31. PubMed ID: 8938947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
